Skip to content
  • About Us
    • Corporate Profile
    • Senior Management
    • Board of Directors
    • Advisors and EDBI Connect
    • Core Values
    • Focal Sectors
  • Why EDBI
    • Why EDBI
    • Impact
    • Value Creation
  • Portfolio
  • News
  • Contact Us
  • About Us
    • Corporate Profile
    • Senior Management
    • Board of Directors
    • Advisors and EDBI Connect
    • Core Values
    • Focal Sectors
  • Why EDBI
    • Why EDBI
    • Impact
    • Value Creation
  • Portfolio
  • News
  • Contact Us
  • About Us
    • Corporate Profile
    • Senior Management
    • Board of Directors
    • Advisors and EDBI Connect
    • Core Values
    • Focal Sectors
  • Why EDBI
    • Why EDBI
    • Impact
    • Value Creation
  • Portfolio
  • News
  • Contact Us
Contact us

Takeda to acquire Inviragen Inc

  • 8 May 2013

Obtains Promising Vaccine Candidates Against Dengue and Hand, Foot and Mouth Disease, Advancing Takeda’s Commitment to Vaccines and Global Health

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now
  • Careers
  • Terms of Use
  • Privacy
  • en
  • cn
  • English

    • English
    • Chinese

    © 2021- edbi. All rights reserved.